Document ID: chunk:federal_register_of_legislation:F2024C00984:schedule:1:p2
Version: federal_register_of_legislation:F2024C00984
Segment Type: schedule
Provision Reference: sch 1 (pt 2/4)
Character Range: 161511–165043

under subsection 85A(1) or (2) of the Act
2.9                                                                  To determine for the purposes of subsection 88(1), (1A), (1C), (1D) or (1E) of the Act a pharmaceutical benefit the supply of which a PBS prescriber referred to in that subsection is authorised to write a prescription, or to vary such a determination
2.10                                                                 To vary the specification of a pharmaceutical item under subsection 84AAA(2) of the Act so that it no longer applies to a pharmaceutical benefit
2.11                                                                 To make a determination about the supply of a pharmaceutical benefit under section 93, 93AA or 93AB of the Act
2.12                                                                 To make or vary a special arrangement under section 100 of the Act to provide for the supply of pharmaceutical benefits
2.13                                                                 To specify a circumstance in which a pharmaceutical benefit may be supplied in a special arrangement made under section 100 of the Act, or to vary an existing special arrangement to specify a new circumstance
2.14                                                                 To vary the circumstances in which a pharmaceutical benefit may be supplied in an existing special arrangement made under section 100 of the Act but not so as to add a new circumstance
2.15                                                                 To agree on a new price for a single brand of a combination item under subsection 99ACC(3) of the Act
                                                                     Note: The Committee may advise the Minister about this under subsection 101(4AC) of the Act.
2.16                                                                 To determine that a pharmaceutical item is an exempt item under section 84AH of the Act
                                                                     Note: The Committee may advise the Minister about this under subsection 101(4AB) of the Act.
2.17                                                                 To revoke or vary, under subsection 101(4AAE) of the Act, a declaration under subsection 85(2A) of the Act so that a listed drug is generally available for supply under Part VII of the Act rather than available only under special arrangements under section 100 of the Act
2.18                                                                 To enter into a deed with a person under section 85E of the Act or to vary a deed entered into with a person under section 85E of the Act
Part 3—Existing pharmaceutical items
3.1                                                                  To determine a brand under subsection 85(6) of the Act for a pharmaceutical item that has a listed brand

Endnotes

Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history

Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend)